Showing results (41-50 of 86) with videos related to
Sort By:
Pageof 9
Cellular & Molecular Biology Letters|November 21, 2008
Perturbation of the lipid phase of a membrane is not involved in the modulation of MRP1 transport activity by flavonoidsOlga Wesołowska, Andrzej B Hendrich, Barbara Łaniapietrzak, et al.Methods in Molecular Biology (Clifton, N.J.)|February 25, 2016
Fluorimetric Methods for Analysis of Permeability, Drug Transport Kinetics, and Inhibition of the ABCB1 Membrane TransporterAna Armada, Célia Martins, Gabriella Spengler, et al.Planta Medica|November 6, 2014
Diterpenes from Euphorbia piscatoria: synergistic interaction of Lathyranes with doxorubicin on resistant cancer cellsMariana A Reis, Angela Paterna, Andreia Mónico, et al.Anticancer Research|July 4, 2012
Inhibitors of bacterial efflux pumps that also inhibit efflux pumps of cancer cellsLeonard Amaral, Gabriella Spengler, Ana Martins, et al.Anticancer Research|October 4, 2011
Modulation of multidrug efflux pump activity by new hydantoin derivatives on colon adenocarcinoma cells without inducing apoptosisGabriella Spengler, Jadwiga Handzlik, Imre Ocsovszki, et al.Phytochemistry|August 8, 2022
Triterpenes from Momordica balsamina (African pumpkin): ABCB1 inhibition and synergistic interaction with doxorubicin in resistant cancer cellsCristina Duarte Silva, Cátia Ramalhete, Gabriella Spengler, et al.Anticancer Research|March 25, 2010
Antitumor-promoting activity of lignans: inhibition of human cytomegalovirus IE gene expressionRozália Pusztai, Marta Abrantes, Julianna Serly, et al.British Journal of Pharmacology|January 14, 2004
3,5-Dibenzoyl-4-(3-phenoxyphenyl)-1,4-dihydro-2,6-dimethylpyridine (DP7) as a new multidrug resistance reverting agent devoid of effects on vascular smooth muscle contractilitySimona Saponara, Masami Kawase, Anamik Shah, et al.In Vivo (Athens, Greece)|January 26, 2006
Benzo[a]phenoxazines: a new group of potent P-glycoprotein inhibitorsOlga Wesolowska, Joseph Molnar, Gunnar Westman, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|October 10, 2002
Chlorpromazine has intracellular killing activity against phagocytosed Staphylococcus aureus at clinical concentrationsDiane Ordway, Miguel Viveiros, Clara Leandro, et al.Pageof 9